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Objective  To evaluate the additive eff  ects of hyaluronidase combined with steroids in patients with peri-articular 
shoulder disorder.
Method  Thirty patients with peri-articular shoulder disorder were given subacromial bursa injections once 
a week for three consecutive weeks. Fifteen patients (Group A) underwent subacromial bursa injections with 
hyaluronidase 1,500 IU, triamcinolone 40 mg and 0.5% lidocaine (total 6 ml). Another fi  fteen patients (Group B) 
underwent the same injections with triamcinolone 40 mg and 0.5% lidocaine (total 6 ml). We examined the active 
range of motion (AROM) in the shoulder, used a visual analogue scale (VAS) for measurement, and administered 
a shoulder disability questionnaire (SDQ) at the commencement of the study and then every week until one week 
after the third injection.
Results  There were no significant difference between group A and B before the injections took place (p>0.05). 
Statistically signifi  cant improvement was seen in the VAS, SDQ, and AROM of fl  exion, abduction, internal rotation 
at one week after the first and second injections compared with the parameters measured at previous visits in 
both groups (p<0.05), except the SDQ between one week after the fi  rst and second injections in group B (p>0.05). 
Improvement in all parameters measured at one week after the third injection compared with the measurement 
values at one week after the second injection were not statistically signifi  cant in both groups (p>0.05). However, 
group A (the hyaluronidase group) showed signifi  cantly greater improvements than group B in terms of their SDQ 
and AROM of internal rotation scores one week after the three injections had taken place (p<0.05).
Conclusion  Peri-articular shoulder disorder patients who underwent subacromial bursa injections using 
hyaluronidase and steroids showed greater functional improvements than those who were given only steroid 
injections.
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INTRODUCTION
  Peri-articular shoulder disorder refers to a range of 
diseases, including subacromial-subdeltioid bursitis, 
calcific tendinitis and rotator cuff tendinopathy or 
tear. It typically causes shoulder pain and a limitation 
in terms of range-of-motion (ROM).
1,2 A subacromial 
bursa injection is commonly used to relieve pain 
and to improve joint function in patients with peri-
articular shoulder disorder, and an injection of steroids 
and lidocaine is the most widely used.
2-5 Yoon et al.
2 
suggested that, compared to a group of patients with 
peri-articular shoulder disorder who were administered 
with low dose steroids, the high dose group showed 
significant improvement in pain control, shoulder 
ROM and shoulder function. However, the higher 
dose group did also experience greater degeneration 
changes and more adverse events in metabolism and 
endocrine system function.
2,6 There is some research 
related to the substitution of steroids with hyaluronic 
acid or combining them with adjuvants, but arguments 
about the effect of this still remain.
7-9 It was shown that 
compared to steroid monotherapy, a combination of 
hyaluronidase and steroids, when injected into scar 
tissue, the nerve root, or injected intraspinally in patients 
with tuberculous arachnoiditis or with failed back surgery 
syndrome, achieved better treatment results.
10-13 Seo et 
al.
13 who specifi  cally studied the shoulder joint, injected 
hyaluronidase and steroids into the articular cavity in 
patients with adhesive capsulitis and reported that there 
were significant improvements in pain relief and ROM, 
when compared to steroid monotherapy. However, there 
has been no research addressing subacromial bursa 
injections of hyaluronidase and steroids in patients with 
peri-articular shoulder disorder. This study therefore 
conducted subacromial bursa injections of steroids and 
hyaluronidase, a combination which is known to increase 
the local anesthetic absorption rate by modifying the 
permeability of the connective tissue, when compared 
with steroid monotherapy. We then, examined whether 
this combination therapy has further effects in the 
treatment of patients with peri-articular shoulder 
disorder.
MATERIALS AND METHODS
Subjects
  Our study group comprised of patients who complained 
of shoulder pain and who came to our rehabilitation 
center from January to June 2011. Th   e inclusion criteria 
were patients (1) who had a painful arc with Hawkin’s 
sign or Neer’s impringement sign; (2) who showed full 
or partial thickness rotator cuff tear or subacromial/
subdeltoid bursitis in ultrasonographic testing, with 
definite lesions in the rotator cuff; and (3) who had 
limitations in terms of their active ROM with stiffness, 
but not to the extent that they met the exclusion criteria 
of having adhesive capsulitis. Th   is condition is diagnosed 
when the patient has normal radiographic findings 
and when the active and passive elevation of arm are 
measured as being less than 100 degrees when the 
patient raises his arms over his head to the maximum 
possible extent; and, when the passive external rotation 
of the glenohumeral joint, which is measured while the 
examiner holds the patient’s wrist and twists his elbow 
up to 90 degrees, is decreased by 50% or more compared 
to the less affected side. Other excluded patients were 
those who have had previous shoulder surgery; who have 
already had injections of steroids or hyaluronic acid for 
the current condition; who suffered from hemiplegic 
shoulder pain syndrome; and, who showed a suspected 
fracture in the radiologic findings. The selected eligible 
patients were randomly placed into A and B groups. 
Subacromial bursa injections
  We conducted physical examination and assessment 
of patients’ shoulder pain and function. Specifi  cally, we 
used ultrasound to examine lesions. We asked the patient 
to move the applicable arm for internal rotation and for 
hyperextension of the arm at a sitting posture placing the 
lower arm on the back. Th   en, we disinfected the area to 
be injected and performed subacromial bursa injections 
under ultrasonographic guidance. We injected a total of 
three times at one week intervals in both groups. The A 
group received 40 mg (1 ml) of triamcinolone acetonide 
(Dong Kwang Pharm., Seoul, Korea) and 3 ml of 1% 
lidocaine with 1ml of hyaluronidase H-lase
® (Kuhnil 
Pharmaceutical, Seoul, Korea) and 1ml of normal saline. 
The B group received 40 mg (1 ml) of triamcinolone 
acetonide and 3 ml of 1% lidocaine with 2 ml of normal The Additive Eﬀ  ects of HA in SA Bursa Injections
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saline; there was a total of 6ml of injection material 
with an 0.5% lidocaine level for each group. One week 
prior to injection, patients were asked to suspend their 
administration of painkillers or anti-inflammatory 
drugs. They were taught to perform scapular stabilizer 
strengthening exercises and range of motion exercises at 
home after the injections; we continuously trained and 
recommended such exercises at every follow-up. There 
was no other physical therapy or drug treatment involved 
in this study.
Evaluation of injection eﬀ  ect
  We evaluated subjects four times: once before their 
fi  rst injection, and one week after their fi  rst, second, and 
third injections. These evaluations were conducted by 
one examiner. This examiner asked patients to report 
the mean value of their degree of pain for the 24 hours 
prior to injection and measured with a visual analog 
scale (from zero to 10 points). He then measured the 
active ROM of patients’ shoulder joints and did not limit 
scapula motion. For shoulder flexion and abduction 
measurement, he asked the patient to extend their elbow 
joints while sitting down and then measured the ROM 
of the upper limb in the sagittal and coronal planes. 
To assess internal and external rotation, the examiner 
measured the range of internal and external rotation that 
the patients had while in a sitting posture and externally 
rotating their shoulders at 90 degrees. Th   e normal range 
of shoulder flexion and abduction was 180 degrees for 
both; for internal and external rotation, it was 90 degrees. 
To evaluate the shoulder function of our patients, we 
used a shoulder disability questionnaire (SDQ). This is 
a tool that can assess the degree of shoulder disorder 
that a patient reports. SDQ’s validity and reliability have 
been verified. It is composed of 22 self-reporting items, 
with results scores ranging from zero (no disability) to 22 
(greatest possible disability).
14
Statistical analysis
  We compared age, gender and lesion between two 
groups by using Chi-square and independent t-tests. We 
also compared measures before patients’ first injection 
and one week after their fi  rst, second, and third injections 
in both the combination and monotherapy groups. We 
used Wilcoxon signed rank testing to compare the two 
groups at each timepoint. SPSS 12.0 was used, at the 0.05 
level of signifi  cance. 
RESULTS
Characteristics and ultrasonic ﬁ  ndings of subjects 
  The study examined 30 people; 15 patients in each 
Table 1. General Characteristics of Subjects
Group A Group B Total
Number of subject 15 15 30
Sex (male/female) 7/8 6/9 13/17
Age (years)   53.8±9.8   55.4±10.0 54.6±9.9
Shoulder aff  ected, n (%)  
Dominant 10 (66.7%) 10 (66.7%) 20 (66.7%)
Non-dominant   5 (33.3%)   5 (33.3%) 10 (33.3%)
VAS     6.4±1.7   6.8±1.9   6.6±1.8
SDQ     8.3±4.9   4.9±3.7   6.6±4.6
Range of motion (degree)
Flexion 165.0±8.6 167.1±16.8 168.2±12.2
Abduction   155.7±25.0 165.0±22.8 162.1±23.8
IR     52.5±13.4   62.9±11.4   57.7±13.3
ER     85.0±11.6   84.3±10.9   84.6±11.0
Values are mean±standard deviation
Group A: Patients injected with 0.5% lidocaine 4 ml+triamcinolone 40 mg+hyaluronidase 1 ml, Group B: Patients 
injected with 0.5% lidocaine 5 ml+triamcinolone 40 mg, VAS: Visual analogue scale, SDQ: Shoulder disability 
questionnaire, IR: Internal rotation, ER: External rotation
*p<0.05 between Group A and Group BSeung Deuk Byun, et al.
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group. There was no significant difference in patients’ 
age, gender and lesion or in individual measures between 
the two groups before injections (Table 1). In addition, 
there was no significant difference in our pre-injection 
ultrasonographic fi  ndings (Table 2). 
 
Changes in visual analog scale (VAS) of pain
  In both groups, a significant improvement in VAS 
was observed after the first injection. Both groups 
also showed significant improvement after the 
second injection, as compared to their status after the 
first injection. There was no statistically significant 
improvement after the third injection compared to the 
point after the second injection (Table 3). However, 
the results after third injection showed that there were 
significant improvement in both groups, compared to 
pre-injection results, but that there was no statistically 
significant difference in improvement between the two 
groups (Table 4).
Table 2. Ultrasonographic Diagnosis before Injection
Findings
Group A 
(n=15)
 Group B 
(n=15)
RC partial-tear 6  6 
RC full-thickness tear 4  4 
SA-SD bursitis 5 5 
Values: number of cases
RC: Rotator cuff  , SA-SD: Subacromial-subdeltoid
Table 3. Summary of Treatment Eff  ects for both Group A and B
Group Pre-injection
1 week after 1
st 
injection
1 week after 2
nd 
injection
1 week after 3
rd 
injection
VAS A     6.4±1.7     2.3±1.2
†       0.5±0.7
‡     0.3±0.5*
B     6.8±1.9     3.5±1.7
†       2.4±1.5
‡     2.4±1.8*
SDQ A     8.8±8.5     3.3±3.5
†       1.2±2.8
‡     0.6±1.5*
B     4.9±3.7     3.8±4.3
†     3.8±4.4     3.6±4.2*
ROM (degree)
Flexion A 165.0±8.5 172.1±9.8
†   177.1±6.1
‡ 177.1±6.1*
B   167.1±17.0 175.0±9.4
† 177.9±4.3 177.1±6.1*
Abduction A   155.7±25.0   168.6±18.8
†   176.8±6.1
‡ 177.8±5.8*
B   165.0±22.8   172.1±10.5
†   176.4±5.0
‡ 176.4±8.4*
Internal rotation A     52.5±13.4     77.9±11.2
†     88.6±3.6
‡   89.3±2.7*
B     62.9±11.4     74.3±10.2
†     81.4±10.3   85.7±8.5*
External rotation A     85.0±11.6  88.6±3.6   90.0±0.0  89.6±1.3
B     84.3±13.3    85.7±11.0   89.3±2.7  89.3±2.7
Values: mean±standard deviation
Group A: Patients who were injected with 0.5% lidocaine 4 ml+triamcinolone 40 mg+hyaluronidase 1 ml (1,500 IU), 
Group B: Patients who were injected with 0.5% lidocaine 5 ml+triamcinolone 40 mg, VAS: Visual analogue scale, SDQ: 
Shoulder disability questionnaire
*p<0.05 pre-injection vs 1 weeks after 3
rd injection, 
†p<0.05 pre-injection vs 1 week after 1
st injection, 
‡p<0.05 1 week 
after 1
st injection vs 1 week after 2
nd injection, 
§p<0.05 1 week after 2
nd injection vs 1 week after 3
rd injection
Table 4. Changes in Measurement Values for Group A 
and B 
Group A Group B
VAS   6.1±1.7   4.4±2.4
SDQ   7.7±4.7*   1.3±1.3
Range of motion (degree)
Flexion 12.1±7.0 10.0±13.0
Abduction 22.1±22.9 11.4±16.1
IR 36.4±12.0* 18.6±7.7
ER   7.3±11.0   5.0±9.4
Values are mean±standard deviation
Group A: Patients injected with 0.5% lidocaine 4 
ml+triamcinolone 40 mg+hyaluronidase 1 ml (1,500 
IU), Group B: Patients injected with 0.5% lidocaine 5 
ml+triamcinolone 40 mg, VAS: Visual analogue scale, 
SDQ: Shoulder disability questionnaire, IR: Internal 
rotation, ER: External rotation
*p<0.05The Additive Eﬀ  ects of HA in SA Bursa Injections
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Changes in SDQ
  In both groups, significant improvement in SDQ 
scores after first injection was observed. After the 
second injection, the A group showed statistically 
significantly improvement, but the B group did not. 
After third injection, there was no statistically signifi  cant 
improvement in either groups, compared to after the 
second injection (Table 3). However, the results after the 
third injection were signifi  cantly improved compared to 
pre-injection results for both groups, more so for group A 
than group B (Table 4).
Changes in the active ROM
  Both groups showed statistically significant improve-
ments in terms of fl  exion and internal rotation after the 
first injection, compared to their pre-injection results. 
Abduction was signifi  cantly improved only in the A group 
after the fi  rst injection. Both groups presented signifi  cant 
improvements in abduction after the second injection 
compared to their status after the first one; however, 
only the A group showed significantly improved in 
fl  exion. After the third injection, there was no statistically 
signifi  cant diff  erence between the two groups, relative to 
their status after the second injection.
  When comparing post-third injection results with 
pre-injection results, both groups showed statistically 
signifi  cant improvements in their fl  exion, abduction and 
internal rotation (Table 3). The A group showed better 
results in terms of their flexion, abduction and internal 
rotation after the third injection compared to their results 
before treatment. Th   e degree of improvement in internal 
rotation was more statistically signifi  cant in the A group 
than it was in the B group (Table 4). 
DISCUSSION
  Subacromial bursa steroid injections are commonly 
repeated in patients with peri-articular shoulder 
disorder; however, there have been multiple debates 
about the appropriate number of injections, intervals and 
the correct dosage to be used.
15-17 To examine appropriate 
doses of steroid, Yoon et al.
2 conducted 1 subacromial 
bursa injection using 10 mg and 40 mg of triamcinolone 
and observed the results after 1, 3 and 6 weeks. Th  is  work 
found no diff  erence in effi   cacy between the 1- and 3-week 
results; however, it reported signifi  cant improvements in 
pain, ROM and function when using 40 mg compared to 
10 mg. To examine the optimum number of injections, 
Tillander et al.
16 performed subacromial bursa injections 
using saline and triamcinolone, injecting these into 
healthy mice a total of eight times (three times at one- 
week intervals and fi  ve times at two-week intervals) and 
examined histologic alterations in rotator cuff activity. 
Th   ey reported that after three injections of triamcinolone, 
there was no histological change in rotator cuff   activity, 
but that there was fragmentation of collagen, necrosis, 
and local inflammation after eight repeated injections. 
In addition, Byun et al.
6 studied the effect of repeated 
steroid injection in patients with hemiplegic shoulder 
pain and diabetes and concluded that the ideal method 
was to conduct three 40 mg triamcinolone injections 
at one-week intervals. Considering both stability 
and efficacy, this study therefore used three 40 mg 
triamcinolone injections administered at one-week 
intervals for our control group. However, there has been 
concern about potential degeneration changes or adverse 
metabolism and endocrine system events caused by 
high-dose steroids,
2,6 which has led to new methods being 
developed that substitute steroids with hyaluronic acid or 
combine them with an adjuvant.
7-9 Th   is study conducted 
combination therapy using steroids and hyaluronidase, 
which is known to be an effective combination when 
used as a spinal root injection or for patients with 
adhesive capsulitis or peri-articular shoulder disorder, 
when compared to using steroid monotherapy. Th  is  study 
therefore aimed to examine whether or not the eff  ect of 
hyaluronidase as an adjuvant increased when decreasing 
the number of steroid injections or whether there were 
adverse events caused by the injections.
10-13
  Hyaluronidase, which is a mammalian water-soluble 
enzyme secreted by the testis or the intestinal canal, 
hydrolyzes the glucosamic bond between hyaluronic 
acid and connective tissues so as to remove the 
interstitial barrier, thereby modifying the permeability 
of connective tissues and reducing the viscosity of 
intercellular interaction.
18 As an absorption enhancer, 
it is subcutaneously injected into tissues with edema so 
that it relieves swelling and edema. Alternatively, it can 
be injected together with local anesthesia or steroids 
to increase permeability, and is therefore widely used 
in ophthalmology, gynecology and anesthesiology.
19,20 
Seo et al.
13 injected hyaluronidase and steroids into Seung Deuk Byun, et al.
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the articular cavity in patients with adhesive capsulitis, 
comparing this to steroid monotherapy. They reported 
that there was no significant difference in VAS scores 
two weeks after injection, but that there were statistically 
significant improvement in abduction and external 
rotation among passive shoulder ROM. The current 
study differed in its subjects and methods compared to 
this study, because its focus was on patients with peri-
articular shoulder disorder and because it examined 
subacromial bursa injections. In addition, our study used 
3 consecutive injections at 1-week intervals. However, 
in this study, no significant difference in VAS was also 
observed between the two groups; however, combination 
therapy did show statistically signifi  cant improvement of 
internal rotation measured by the shoulder function scale 
and active shoulder ROM than did the monotherapy. 
Th   is suggests that hyaluronidase combined with steroids 
increases capillary permeability, which in turn facilitates 
the absorption of bursa fluid in subacromial bursitis 
and enhances the permeability of steroids into rotator 
cuff   lesions in order to suppress the infl  ammation of the 
tendon around the lesion.
  Between the second and third injections, both groups 
presented no statistically significant improvements in 
their VAS, on the shoulder function scale or in terms of 
their active ROM. When deciding on the appropriate 
number of steroid injections, further studies that observe 
various diseases and have a larger sample will be 
necessary. However, according to our results, patients 
with peri-articular shoulder disorder will benefit 
most from subacromial bursa injections of 40 mg 
triamcinolone administered two times. 
  As we studied patients with peri-articular shoulder 
disorder, we excluded patients with a capsular pattern. 
It is, however, difficult to identify early adhesive 
capsulitis because it is similar to shoulder impingement 
syndrome. Th   erefore, this study might be limited because 
it did not completely exclude patients who had early 
adhesive capsulitis. On the other hand, we selected 
patients who had definite lesions shown by ultrasonic 
fi  ndings and who experienced stiff  ness; these measures 
should have meant that patients with early adhesive 
capsulitis were likely to be excluded. Recently, methods 
for distinguishing early adhesive capsulitis through 
ultrasonographic testing have been developed,
21,22 which 
may be useful for further studies such as ours when 
selecting eligible subjects. Another limitation may be 
that long-term eff  ect of combination therapy is not clear 
due to our small sample size and short follow-up period. 
Th   erefore, further study in this area should have a larger 
sample size and extend the follow-up period. 
CONCLUSION
  Subacromial bursa injections of steroids (40 mg 
triamcinolone) and hyaluronidase in patients with peri-
articular shoulder disorder may have an additive effect 
in causing improvement of internal rotation active ROM 
and improving shoulder joint function.
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